- Report
- August 2024
- 169 Pages
Global
From €2266EUR$2,500USD£1,931GBP
- Report
- July 2024
- 109 Pages
Global
From €4306EUR$4,750USD£3,668GBP
- Report
- February 2024
- 130 Pages
Global
From €4306EUR$4,750USD£3,668GBP
- Report
- April 2023
- 140 Pages
Global
From €4486EUR$4,949USD£3,822GBP
- Report
- December 2023
- 114 Pages
From €3127EUR$3,450USD£2,664GBP
- Report
- September 2023
- 179 Pages
Global
From €3626EUR$4,000USD£3,089GBP
- Report
- September 2024
- 173 Pages
Global
From €3626EUR$4,000USD£3,089GBP
- Report
- July 2024
- 68 Pages
Global
From €2266EUR$2,500USD£1,931GBP
- Report
- July 2024
- 185 Pages
Global
From €3626EUR$4,000USD£3,089GBP
- Report
- May 2024
- 128 Pages
Global
From €3626EUR$4,000USD£3,089GBP
- Report
- June 2025
- 147 Pages
Global
From €3581EUR$3,950USD£3,050GBP
- Report
- July 2025
- 217 Pages
Global
From €4528EUR$4,995USD£3,858GBP
- Report
- January 2025
- 186 Pages
Global
From €4528EUR$4,995USD£3,858GBP
- Report
- October 2023
- 265 Pages
Global
€4165EUR$4,595USD£3,549GBP
- Report
- June 2025
- 144 Pages
Global
From €3581EUR$3,950USD£3,050GBP
- Report
- April 2024
- 124 Pages
Global
From €3581EUR$3,950USD£3,050GBP
- Report
- May 2026
- 150 Pages
Japan
From €4396EUR$4,850USD£3,746GBP
- Report
- May 2026
- 150 Pages
Malaysia
From €4396EUR$4,850USD£3,746GBP
- Report
- May 2026
- 150 Pages
South Korea
From €4396EUR$4,850USD£3,746GBP
- Report
- May 2026
- 150 Pages
Spain
From €4396EUR$4,850USD£3,746GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more